Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis.

Rheumatology (Oxford, England)

Volumn 50, Issue 8, 2011, Pages 1445-1452

  Pascual Salcedo, Dora ^a   Plasencia, Chamaida ^b   Ramiro, Susana ^b   Nuño, Laura ^b   Bonilla, Gema ^b   Nagore, Daniel ^b   Ruiz Del Agua, Ainhoa ^b   Martínez, Antonio ^b   Aarden, Lucien ^b   Martín Mola, Emilio ^b   Balsa, Alejandro ^b  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIRHEUMATIC AGENT; INFLIXIMAB; METHOTREXATE; MONOCLONAL ANTIBODY;

ARTICLE; BLOOD; DRUG COMBINATION; DRUG TOLERANCE; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ANTIBODIES; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; DRUG TOLERANCE; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79960935860     PISSN: None     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker124     Document Type: Article

References (0)